Fuzhou Corona Science & Technology Development Co., Ltd. (hereinafter referred to as "Fuzhou Corona"), established in 1956 and reformed from state-owned Chinese traditional medicine enterprises - Fuzhou Corona factory, owns the famous brand of Chinese medicine "Wu He" trademark. After 60 years of development, Fuzhou Corona has grown into a state-level high-tech enterprise specialized in the R&D, production and sales of traditional Chinese medicine APIs, plant extracts, functional food and health care products. Also as part of the national 125 plan which focused on supporting the life and health industry, the company was listed in 2015.
Fuzhou Corona is a modern pharmaceutical company that is strictly in accordance with GMP standards for production management. The company is licensed for pharmaceutical, food and food additives production, and owns the United States FDA approved dietary supplement cGMP/NFS certificate, ECOCERT SA certification issued by the United States organic NOP certificate and European organic EOS certificate, and has passed HACCP, ISO9001:2008, kosher food (KOSHER), halal food (HALAL) and other quality systems.
Fuzhou Corona now has more than 2000 square meters of R&D and testing center, equipped with advanced analytical instruments including High Performance Liquid Chromatography, Gas Chromatography, Atomic Absorption Spectroscopy, Ultraviolet Spectrometer, Infrared Spectrometer, Thin-layer Chromatograph, etc. Fuzhou Corona Engineering Technology Center, which was named "Ningbo Municipal Engineering Center", composed of multiple doctor, master's degree, has first-class new products R&D and quality control capabilities. As a graduate education base in Zhejiang, the company jointly trains doctoral and master's students with Zhejiang University. The company has been approved 2 national Spark program projects, 2 city-level major projects, and 7 authorized invention patents.
Fuzhou Corona has 4 production lines, including two sets of automatic continuous reverse flow extraction equipment and supporting resin column separation production line, with daily raw material processing capacity of more than 30 tons, and annual processing of Chinese herbal medicine and other efficacy plant raw materials more than 10,000 tons. Company's products have been widely used in drugs, health care products, food, food additives, feed, tobacco, daily cosmetics and other industries.
Fuzhou Corona has been committed to research and development of high-efficiency extraction of high-quality Chinese medicine ingredients, focused on the traditional Chinese "medicinal food dual-use" herbal extracts, supplemented by natural herbal extracts widely recognized by the Western developed countries. We mainly focus on the development of natural plant active ingredients which can help with liver protection, anti-aging, anti-cancer, antioxidant, energy enhancement and human immunity improvements.
Fuzhou Corona has mature technology and equipment capacity to produce more than 100 kinds of standardized plant extract to meet global market demands. The main products include turmeric extract, ginkgo biloba extract, huperzia serrata extract, grape seed extract, rhodiola rosea extract, mucuna seed extract, giant knotweed extract, NHDC and so on. As the top turmeric extract manufacturer in China, the company is the drafter of national standards and international business standards for curcumin, and the mender of USP standards of the product in the US. The company exports 60% of the products to Europe, US, Japan and other developed countries, and has cooperative relations with International well-known enterprises such as Wal-Mart, Amway, GNC, Robinson, etc. The main domestic customers include BYHEALTH, HERBALIFE, INFINITUS, Pien Tze Huang, Yunnan Baiyao and other health care products manufacturer.
Fuzhou Corona has two wholly-owned subsidiaries, Best Global Nutrition Inc. in Los Angeles, USA, and Zhejiang Kangjin Biotechnology Co., Ltd., located in Kaihua County, Zhejiang Province. The latter covers an area of 40 acres, with building area of more than 5000 square meters, in the hope to solve the potential production capacity limits in the future.